Oxidative Stress and Genetic Variants of Xenobiotic-Metabolising Enzymes Associated with COPD Development and Severity in Serbian Adults

References

• Celli BR, MacNee W, Agusti A, Anzueto A, Berg B, Buist AS, et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932–946.
   PubMed Web of Science ®Google Scholar
• Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004; 364:709–721.
   PubMed Web of Science ®Google Scholar
• MacNee W. Pathogenesis of Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 2005; 2:258–266.
   PubMedGoogle Scholar
• Lin JL, Thomas PS. Current Prospectives of Oxidative Stress and its Measurement in Chronic Obsructive Pulmonary Disease. COPD 2010; 7(4):291–306.
   PubMedGoogle Scholar
• Løkke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax 2006; 61(11):935–939.
   PubMed Web of Science ®Google Scholar
• Castell JV, Donato MT, Gómez-Lechón MJ. Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach. Exp Toxicol Pathol 2005; 57(Suppl 1):189–204.
   PubMed Web of Science ®Google Scholar
• Zidzik J, Slabá E, Joppa P, Kluchová Z, Dorková Z, Skyba P, et al. Glutathione S-transferase and Microsomal Epoxide Hydrolase Gene Polymorphisms and Risk of Chronic Obstructive Pulmonary Disease in Slovak Population. Croat Med J 2008; 49(2):182–191.
   PubMed Web of Science ®Google Scholar
• Park JY, Chen L, Wadhwa N, Tockman MS. Polymorphisms for microsomal epoxide hydrolase and genetic susceptibility to COPD. Int J Mol Med 2005; 15(3):443–448.
   PubMed Web of Science ®Google Scholar
• Cheng SL, Yu CJ, Chen CJ, Yang PC. Genetic polymorphismn of epoxide hydrolase and glutathione S-transferase in COPD. Eur Respir J 2004; 23(6):818–824.
   PubMed Web of Science ®Google Scholar
• Penyige A, Poliska S, Csanky E, Scholtz B, Dezso B, Schmelczer I, et al. Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study. BMC Med Genet 2010; 11:152.
   PubMed Web of Science ®Google Scholar
• Li H, Fu WP, Hong ZH. Microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease: A comprehensive meta-analysis. Oncol Lett 2013; 5(3):1022–1030.
   PubMed Web of Science ®Google Scholar
• Omiecinski CJ, Hassett C, Hosagrahara V. Epoxide hydrolase—polymorphism and role in toxicology. Toxicol Lett 2000; 112–113:365–370.
   PubMed Web of Science ®Google Scholar
• Hassett C, Aicher L, Sidhu JS, Omiecinski CJ. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 1994; 3(3):421–428.
   PubMed Web of Science ®Google Scholar
• Benhamou S, Reinikainen M, Bouchardy C, Dayer P, Hirvonen A. Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res 1998; 58(23):5291–5293.
   PubMed Web of Science ®Google Scholar
• Hayes JD, Strange RC. Glutathione-S-transferase polymorphisms and their biological consequence. Pharmacology 2000; 61(3):154–166.
   PubMed Web of Science ®Google Scholar
• Seidegard J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA 1988; 85(19):7293–7297.
   PubMed Web of Science ®Google Scholar
• Neofytou E, Tzortzaki EG, Chatziantoniou A, Siafakas NM. DNA Damage Due to Oxidative Stress in Chronic Obstructive Pulmonary Disease (COPD). Int J Mol Sci 2012; 13(12):16853–16864.
   PubMed Web of Science ®Google Scholar
• European Standards Committee on Urinary (DNA) Lesion Analysis, Evans MD, Olinski R, Loft S, Cooke MS. Toward consensus in the analysis of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine as a noninvasive biomarker of oxidative stress. FASEB J 2010; 24(4):1249–1260.
   PubMed Web of Science ®Google Scholar
• Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159(1):179–187.
   PubMed Web of Science ®Google Scholar
• Stankovic M, Nikolic A, Tomovic A, Mitic-Milikic M, Nagorni-Obradovic Lj, Petrović-Stanojevic N, et al. Association of functional variants of phase I and II genes with chronic obstructive pulmonary disease in a Serbian population. J Med Biochem 2015; 34(2):207–214.
   PubMed Web of Science ®Google Scholar
• Topic A, Francuski D, Markovic B, Stankovic M, Dobrivojevic S, Drca S, et al. Gender-related reference intervals of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine determined by liquid chromatography-tandem mass spectrometry in Serbian population. Clin Biochem 2013; 46(4–5):321–326.
   PubMed Web of Science ®Google Scholar
• Igishi T, Hitsuda Y, Kato K, Sako T, Burioka N, Yasuda K, et al. Elevated urinary 8-hydroxydeoxyguanosine, a biomarker of oxidative stress, and lack of association with antioxidant vitamins in chronic obstructive pulmonary disease. Respirology 2003; 8(4):455–460.
   PubMed Web of Science ®Google Scholar
• Dizdaroglu M. Oxidatively induced DNA damage and its repair in cancer. Mutat Res Rev Mutat Res 2015; 763:212–245.
   PubMed Web of Science ®Google Scholar
• Morlá M, Busquets X, Pons J, Sauleda J, MacNee W, Agustí AG, et al. Telomere shortening in smokers with and without COPD. Eur Respir J 2006; 27(3):525–528.
   PubMed Web of Science ®Google Scholar
• Savale L, Chaouat A, Bastuji-Garin S, Marcos E, Boyer L, Maitre B, et al. Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 179:566–571.
   PubMed Web of Science ®Google Scholar
• Boyer L, Chouaïd C, Bastuji-Garin S, Marcos E, Margarit L, Le Corvoisier P, et al. Aging-Related Systemic Manifestations in COPD Patients and Cigarette Smokers. PLoS One 2015; 10(3):e0121539.
   Google Scholar
• Benetos A, Okuda K, Lajemi M, Kimura M, Thomas F, Skurnick J, et al. Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulsewave velocity. Hypertension 2001; 37(2 Pt 2):381–385.
   PubMed Web of Science ®Google Scholar
• Gan WQ, Man SF, Postma DS, Camp P, Sin DD. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res 2006; 7:52.
   PubMed Web of Science ®Google Scholar
• Hakim IA, Harris R, Garland L, Cordova CA, Mikhael DM, Sherry Chow HH. Gender difference in systemic oxidative stress and antioxidant capacity in current and former heavy smokers. Cancer Epidemiol Biomarkers Prev 2012; 21(12):2193–2200.
   PubMed Web of Science ®Google Scholar
• Chen CZ, Wang RH, Lee CH, Lin CC, Chang HY, Hsiue TR. Polymorphism of microsomal epoxide hydrolase is associated with chronic obstructive pulmonary disease and bronchodilator response. J Formos Med Assoc 2011; 110(11):685–689.
   PubMed Web of Science ®Google Scholar
• Mehrotra S, Sharma A, Kumar S, Kar P, Sardana S, Sharma JK. Polymorphism of glutathione S-transferase M1 and T1 gene LOCI in COPD. Int J Immunogenet 2010; 37(4):263–267.
   PubMed Web of Science ®Google Scholar
• Yim JJ, Park GY, Lee CT, Kim YW, Han SK, Shim YS, et al. Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax 2000; 55(2):121–125.
   PubMed Web of Science ®Google Scholar
• Lakhdar R, Denden S, Kassab A, Leban N, Knani J, Lefranc G, et al. Update in chronic obstructive pulmonary disease: role of antioxidant and metabolizing gene polymorphisms. Exp Lung Res 2011; 37(6):364–375.
   PubMed Web of Science ®Google Scholar
• Gaspar P, Moreira J, Kvitko K, Torres M, Moreira A, Weimer T. CYP1A1, CYP2E1, GSTM1, GSTT1, GSTP1, and TP53 polymorphisms: do they indicate susceptibility to chronic obstructive pulmonary disease and non-small-cell lung cancer?. Genet Mol Biol 2004; 27(2):133–138.
   Web of Science ®Google Scholar
• Faramawy MM, Mohammed TO, Hossaini AM, Kashem RA, Abu Rahma RM. Genetic polymorphism of GSTT1 and GSTM1 and susceptibility to chronic obstructive pulmonary disease (COPD). J Crit Care 2009; 24(3):7–10.
   Web of Science ®Google Scholar
• Sin DD, Cohen SB, Day A, Coxson H, Paré PD. Understanding the Biological Differences in Susceptibility to Chronic Obstructive Pulmonary Disease between Men and Women. Proc Am Thorac Soc 2007; 4(8):671–674.
   PubMedGoogle Scholar
• Chappell S, Daly L, Morgan K, Guetta-Baranes T, Roca J, Rabinovich R, et al. Genetic variants of microsomal epoxide hydrolase and glutamate-cysteine ligase in COPD. Eur Respir J 2008; 32(4):931–937.
   PubMed Web of Science ®Google Scholar
• Matheson MC, Raven J, Walters EH, Abramson MJ, Ellis JA. Microsomal epoxide hydrolase is not associated with COPD in a community-based sample. Hum Biol 2006; 78(6):705–717.
   PubMed Web of Science ®Google Scholar
• Smith CA, Harrison DJ. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 1997; 350:630–633.
   PubMed Web of Science ®Google Scholar
• GOLD. Global Strategy for Diagnosis, Management, and Prevention of COPD. http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html. Updated January 2015.
   Google Scholar
• Sandford AJ, Chagani T, Weir TD, Connett JE, Anthonisen NR, Paré PD. Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med 2001; 163(2):469–473.
   PubMed Web of Science ®Google Scholar